biotechnology companies

Companies whose enriched business profile is tagged “biotechnology”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Regeneron Pharmaceuticals (REGN) Health Care — Regeneron is a leading biotechnology firm that leverages its human genetics research and proprietary technology to discover and commercialize innovative therapies for serious diseases. ask →
• Corteva (CTVA) Materials — Corteva is a global agriculture leader specializing in advanced seed technology and crop protection solutions to support sustainable farming. ask →
• PROTAGONIST THERAPEUTICS INC (PTGX) Health Care — Protagonist Therapeutics is a biopharmaceutical company developing novel peptide-based therapies to treat chronic diseases through internal research and strategic collaborations. ask →
• CRISPR THERAPEUTICS AG (CRSP) Health Care — CRISPR Therapeutics is a biopharmaceutical company pioneering gene-editing therapies to treat and potentially cure severe genetic diseases using its proprietary CRISPR/Cas9 technology. ask →
• TARSUS PHARMACEUTICALS INC (TARS) Health Care — Tarsus Pharmaceuticals is an ophthalmology-focused biopharmaceutical company best known for XDEMVY, a treatment for Demodex blepharitis. ask →
• ATAIBECKLEY INC (ATAI) Health Care — Atai Beckley is a clinical-stage biotech firm developing novel treatments for central nervous system disorders. ask →
• IMMUNOME INC (IMNM) Health Care — Immunome is a clinical-stage biotechnology company leveraging a proprietary platform to discover and develop novel, targeted oncology therapeutics. ask →
• XENCOR INC (XNCR) Health Care — A clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines using its proprietary protein engineering platforms to treat cancer and autoimmune diseases. ask →
• INHIBRX BIOSCIENCES INC (INBX) Health Care — Inhibrx Biosciences is a clinical-stage biotechnology company leveraging advanced protein engineering to develop targeted therapeutic candidates for complex diseases. ask →
• FORTE BIOSCIENCES INC (FBRX) Health Care — A clinical-stage biopharmaceutical company focused on the development of novel therapies for dermatological and autoimmune conditions. ask →
• CULLINAN THERAPEUTICS INC (CGEM) Health Care — Cullinan Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of targeted therapies for cancer and autoimmune diseases. ask →
• ARBUTUS BIOPHARMA CORP (ABUS) Health Care — A clinical-stage biopharmaceutical company developing novel treatments for chronic hepatitis B while generating value from its lipid nanoparticle drug delivery patent portfolio. ask →
• LEXICON PHARMACEUTICALS INC (LXRX) Health Care — Lexicon Pharmaceuticals is a biopharmaceutical company leveraging proprietary gene-knockout technology to discover and develop small molecule drugs for significant unmet medical needs. ask →
• MINERVA NEUROSCIENCES INC (NERV) Health Care — A clinical-stage biotechnology company developing potential treatments for the negative symptoms of schizophrenia. ask →
• State Street Health Care Select Sector SPDR ETF (XLV) — A sector-specific ETF providing broad exposure to companies across the entire U.S. health care landscape, from major pharmaceuticals to medical device manufacturers. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-10-08.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.